Daily non-political popular news in brief.

IAVI statement on new analysis of STEP large-scale AIDS vaccine trial

The International AIDS Vaccine Initiative issued the following statement from its president and CEO, Dr. Seth Berkley, following the release of the first analysis of the entire study population from a late-stage AIDS vaccine trial, known as the STEP study.

Read more »

Keywords: iavi, statement, analysis, step, large-scale, aids, vaccine, trial, analysi, large, scale, aid

« Previous | Next »

Similar news on "IAVI statement on new analysis of STEP large-scale AIDS vaccine trial":

1. International AIDS Vaccine Initiative (IAVI) statement on male circumcision
   12-14-2006 · EurekAlert!
   The International AIDS Vaccine Initiative (IAVI) issued this statement today following a National Institutes of Health (NIH) decision to end two clinical trials of adult male circumcision in Uganda and Kenya. The NIH's Data Safety and Monitoring Board (DSMB), reviewing interim data, found that medically performed circumcision significantly protected men in the trial from HIV infection.
   Similar news · Read more »
   
2. First large-scale HIV vaccine trial in South Africa opens
   02-08-2007 · EurekAlert!
   A large-scale clinical trial of a candidate HIV vaccine -- which previously showed promise in smaller studies in the United States and elsewhere -- has now opened in South Africa. The study plans to enroll up to 3,000 HIV-negative men and women, making it the largest African HIV vaccine trial to date.
   Similar news · Read more »
   
3. Africa's first large-scale HIV vaccine study launches
   02-08-2007 · EurekAlert!
   The launch of the first large-scale study to evaluate a candidate HIV vaccine on the African continent was announced today by study collaborators in the United States and South Africa. The trial will involve up to 3,000 participants at five sites throughout South Africa and is expected to continue for four years.
   Similar news · Read more »
   
4. Pediatric AIDS Vaccine Research Could Help Prevent Mother-to-child Transmission Through ...
   10-13-2006 · ScienceDaily
   Scientists at Makerere University, in Kampala, Uganda, along with scientists from Johns Hopkins and other institutions worldwide, have begun the first clinical safety trial in Africa of a vaccine to prevent mother-to-child transmission of HIV through breastfeeding.
   Similar news · Read more »
   
5. Hopkins joins Ugandan researchers to study pediatric AIDS vaccine
   10-13-2006 · EurekAlert!
   Scientists at Makerere University, in Kampala, Uganda, along with scientists from Johns Hopkins and other institutions worldwide, have begun the first clinical safety trial in Africa of a vaccine to prevent mother-to-child transmission of HIV through breastfeeding.
   Similar news · Read more »
   
6. 30+ AIDS vaccine clinical trials in 24 countries, research occurring on every continent
   01-31-2007 · EurekAlert!
   The International AIDS Vaccine Initiative's (IAVI) January 2007 Annual Issue of VAX, an editorially independent bulletin on AIDS vaccine research published by IAVI, reports that 13 new preventive AIDS vaccine trials were initiated in eight countries around the world in 2006. There are now more than 30 trials ongoing in 24 countries, across every continent.
   Similar news · Read more »
   
7. Kilogram quantities at last!
   02-04-2008 · EurekAlert!
   Through a combination of one biotechnological and one chemical step, and starting from sunflower oil, A. Giannis and co-workers from the University of Leipzig, have devised a large-scale synthesis of (2R-3S)-isocitric acid, the last intermediate in the citric acid cycle to become available in bulk quantities.
   Similar news · Read more »
   
8. High-tech research shows cocaine changes proteins and brain function
   10-31-2006 · EurekAlert!
   In the first large-scale analysis of proteins in the brains of individuals addicted to cocaine, researchers have uncovered novel proteins and mechanisms that may one day lead to new treatment options to fight addiction.
   Similar news · Read more »
   
9. Power switch
   09-20-2007 · EurekAlert!
   The wisest energy strategy for the United States and other countries facing similar challenges is to move away from their reliance on large-scale centralized coal and nuclear plants, and instead, invest in renewable energy systems and small scale decentralized generation technologies. According to Benjamin Sovacool from the Virginia Polytechnic Institute and State University, these alternative technologies are simultaneously feasible, affordable, environmentally friendly, reliable and secure. His analysis is published in Springer's journal Policy Sciences.
   Similar news · Read more »
   
10. Human trial results show excellent safety data, from Geovax's DNA/MVA AIDS vaccines
    02-06-2007 · EurekAlert!
    GeoVax Labs, Inc. an Atlanta-based biotechnology company, today reported successful early results from two ongoing AIDS prevention Phase I human vaccine trials. Results from the first low-dose trial indicate a good safety profile as well as positive immune responses in human volunteers receiving 1/10th dose of GeoVax's AIDS vaccine. Results from a second larger full-dose trial also indicate a good safety profile in participants.
    Similar news · Read more »